Daniel Lin, Associate Professor of Medical Oncology at Thomas Jefferson University Hospitals, shared a post on X:
“Honored to have had the opportunity to discuss the ILUSTRO and HERIZON-GEA-01 studies presented by Dr. Kohei shitara and Dr. Elimova at ASCO GI26 Biomarker driven progress in advanced gastroesophageal cancers.”
More posts featuring ASCO GI26.